ModraDoc006/r in Patients With Breast Cancer
NCT03890744
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Breast Cancer
Recurrent Breast Cancer
Interventions
DRUG:
ModraDoc006/r
Sponsor
Modra Pharmaceuticals